Skip to main content
Caplight Logo









Debut

Debut

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.debutbiotech.com/

Last Round

VC Round

Aug 26, 2025

Total Funding Raised

$105.3M

Company Overview

Debut is a biotechnology company that develops advanced cell-free biomanufacturing platforms and AI-driven discovery tools to produce sustainable, high-performance bioactive ingredients for the cosmetics and skincare industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

cell-free biomanufacturingbiotech ingredientslab-grown ingredientsAI ingredient discoverysynthetic biologybio-identical ingredientscosmetic R&Dcontract manufacturingsustainable beautyingredient innovationbiotechsynbioclean beautybiotech platformcustom formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Debut Comparables

Compare Debut with similar companies based on industry and business-model similarity.

Debut comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enzymit
84%
Cambrium
83%
Arcaea
82%

Debut Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 26, 2025
Series BOct 19, 2023
Series BJun 12, 2023
Series AAug 12, 2021
SeedJan 7, 2020

Key People

Founding team and executive leadership

Joshua Britton

Chief Executive Officer

Executive Team

Debut Investors

Notable investors and investment history

Debut investors
InvestorRounds
Better VenturesSeed
Fine Structure VenturesSeries A, Series B, VC Round
FTW VenturesSeed
Cultivian Sandbox VenturesSeries A, Series B
GS FuturesSeries B, VC Round
Cantos VenturesSeries A
Cavallo VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2026

    Derek Wanner appointed as new Chief Commercial Officer.

  • Aug 26, 2025

    $20M raised from BOLD, EDBI, and GS Futures.

Recent news

Latest coverage and updates

  • is_developingSep 25, 2026

    Debutbiotech, Inc. is developing fermentation-based ingredients for beauty and personal care products on Jul 1st '25.

  • is_developingJul 21, 2026

    Debut will develop AI-discovered skin longevity ingredient on Jul 1st '27.

Debut Filings

Explore SEC and related filing metadata, where available.

Debut filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Debut's valuation, stock price, and market status.

Is Debut a public or private company?

Debut is a private company.

What is the current stock price of Debut?

Debut is a private company with no public stock price. No recent secondary market data is available.

How much is Debut worth (valuation)?

Valuation information for Debut is not publicly available.

Can I buy Debut stock?

Debut shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Debut's last funding round?

Debut's most recent funding round was Early Funding on August 26, 2025.

Who are the main investors in Debut?

Key investors in Debut include Material Impact, BOLD (Business Opportunities for L'Oréal Development), KdT Ventures.

Will Debut IPO soon?

No public IPO plans have been announced for Debut.

How can I track Debut secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Debut's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range60
Year Founded2019
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?